vTv Therapeutics Inc.

TickerCurrent Price% Daily ChangeVolume (1,000s)Average Volumn (1,000s)Market Cap (Millions)1/2/2024 Price% Change Since Inception 1/2/2024

Contact Information

vTv Therapeutics Inc.
3980 Premier Drive
Suite 310
High Point, NC 27265
United States

vTv is a clinical stage biotechnology company with a pipeline of drug candidates led by TTP399, a potentially transformative treatment for the reduction of hypoglycemic episodes in type 1 diabetes patients.